NurExone Presenting on Revolutionary Spinal Cord Injury Therapy at European Conference on Exosomes and Regenerative Medicine

19.04.2024 - TORONTO and HAIFA, Israel, April 19, 2024 (GLOBE NEWSWIRE) - NurExone Biologic Inc. (TSXV: NRX) (Germany: J90) (the “Company” or “NurExone”), a pioneering biopharmaceutical company, is pleased to announce that Dr. Lior Shaltiel, CEO and Director ... Seite 1

Related Keywords

Germany , Canada , London , City Of , United Kingdom , Exosomes Europe , Eva Reuter , Lior Shaltiel , Nurexone Biologic Inc , Thesis Capital Inc , Facebook , Exone Biologic , Central Nervous System , Orphan Drug Designation , Executive Officer , Nurexone Biologic Chart , Urexone Biologic Kurs , Urexone Biologic Aktie ,